Some immunocompromised patients depend on herd immunity for protection
Immunocompromised advocates are asking more people to get vaccinated to offer the most vulnerable protection. Share Updated: 7:22 AM PDT May 13, 2021
Immunocompromised advocates are asking more people to get vaccinated to offer the most vulnerable protection. Share Updated: 7:22 AM PDT May 13, 2021
Hide Transcript
Show Transcript California families can now schedule an appointment for their 12 to 15 year olds to get the fighter covid 19 vaccine. To schedule an appointment, you can go to my turn CIA dot gov. That expanded eligibility comes after the FDA granted emergency use authorization of the vaccine And the CDC approved the shot for those as young as 12. About 2.1 million Californians fall into this age group. Action is a reporter. Christopher Salis has more on California s decision to expand eligibility. The decision came from the state last night at around 10 p.m. and t
USA TODAY
To prove their COVID-19 vaccines worked, companies had to enroll more than 100,000 participants in monthslong clinical trials. Next time, Peter Gilbert wants such tests to require only a few hundred people and eight weeks time.
To get there, Gilbert and others have to figure out how much protection people need to avoid hospitalization and death from COVID-19, or even to prevent getting infected at all.
But 15 months after COVID-19 shut down most of the world, it s still not clear what level of immune protection is enough. I haven t seen people tossing around a number, and I m a little surprised by that. I would have thought we were further along by now, said John Grabenstein, editor for the Immunization Action Coalition and former senior scientist and director for the U.S. Department of Defense military immunization program.
. (Tribune News Service) To prove their COVID-19 vaccines worked, companies had to enroll more than 100,000 participants in monthslong clinical trials. Next time, Peter Gilbert wants such tests to require only a few hundred people and eight weeks time. To get there, Gilbert and others have to figure out how much protection people need to avoid hospitalization and death from COVID-19, or even to prevent getting infected at all. But 15 months after COVID-19 shut down most of the world, it s still not clear what level of immune protection is enough. I haven t seen people tossing around a number, and I m a little surprised by that. I would have thought we were further along by now, said John Grabenstein, editor for the Immunization Action Coalition and former senior scientist and director for the U.S. Department of Defense military immunization program.
What level of antibodies protect against COVID-19? Researchers are rushing to find out Elizabeth Weise, USA TODAY
Replay Video UP NEXT
To prove their COVID-19 vaccines worked, companies had to enroll more than 100,000 participants in monthslong clinical trials. Next time, Peter Gilbert wants such tests to require only a few hundred people and eight weeks time.
To get there, Gilbert and others have to figure out how much protection people need to avoid hospitalization and death from COVID-19, or even to prevent getting infected at all.
But 15 months after COVID-19 shut down most of the world, it s still not clear what level of immune protection is enough.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
FDA expands indication for CoolSeal™ Trinity 5 mm Vessel Sealer to include pediatric patients
Bolder Surgical HoldingsMay 10, 2021 GMT
LOUISVILLE, COLORADO, May 10, 2021 (GLOBE NEWSWIRE) Bolder Surgical today announced expanded indication to the FDA 510(k) clearance for the CoolSeal™ Trinity 5 mm Laparoscopic Vessel Sealer, Divider, and Dissector to include surgical procedures for pediatric patients including infants, children, and adolescents.
CoolSeal Trinity is part of the Bolder Surgical’s vessel sealing portfolio of products designed for pediatric and adult surgery. The larger vessel sealing capacity and cutting functionality of CoolSeal Trinity complements the 3 mm CoolSeal Mini, providing pediatric surgeons with unprecedented device choices to streamline workflow and support patient outcomes.